TCG GreenChem, Inc. was conceptualized by Dr. Chris H. Senanayake (Founder and CEO & CSO) and Dr. Joseph D. Armstrong, Ill (COO), former pharmaceutical executives with a track record in the development of hundreds of New Chemical Entities (NCE) into the clinic and commercialization of several well-known pharmaceutical products for Boehringer Ingelheim Pharmaceuticals, Inc., Sepracor, Inc., and Merck & Co, Inc. The senior leadership brings the experience, technological expertise, and know-how, which is required to manufacture architecturally complex intermediates and APls by utilizing state of the art synthetic organic chemistry and cutting-edge technology platforms such as catalysis and continuous flow chemistry.
TCG GreenChem, Inc. is positioned as a contract innovation company that provides CDMO services with a unique modus operandi in the space of supporting pharmaceutical R&D. Moreover, through strategic collaborations with a select group of technology and manufacturing companies in United States, Asia, and Europe, TCG GreenChem, Inc. offers the cGMP manufacturing reliability in United States and India which is needed to meet today's regulatory and supply-chain challenges. TCG GreenChem, Inc. is the US subsidiary of TCG Lifesciences Pvt. Ltd., (formerly "Chembiotek Research International") a leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery, development and commercialization. TCG Lifesciences started operations in 2001in Kolkata, India and currently has its presence in the United States, Europe, and Japan. TCGLS and its subsidiaries have a strong talent pool of more than 1,500 scientists, of which over 300 have PhDs and the balance hold master's degrees: drawn from the best domestic and international institutes and industry.
Some of our services are.
1. Innovative Process Research and Development, Catalysis, Crystallization and Flow Chemistry.
2. Scale-up of APIs under cGMP and nonGMP conditions in Princeton, NJ.
3. Synthesis of stable labeled metabolites and APIs, impurities, Glucuronides.
TCG GreenChem, Inc. is positioned as a contract innovation company that provides CDMO services with a unique modus operandi in the space of supporting pharmaceutical R&D. Moreover, through strategic collaborations with a select group of technology and manufacturing companies in United States, Asia, and Europe, TCG GreenChem, Inc. offers the cGMP manufacturing reliability in United States and India which is needed to meet today's regulatory and supply-chain challenges. TCG GreenChem, Inc. is the US subsidiary of TCG Lifesciences Pvt. Ltd., (formerly "Chembiotek Research International") a leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery, development and commercialization. TCG Lifesciences started operations in 2001in Kolkata, India and currently has its presence in the United States, Europe, and Japan. TCGLS and its subsidiaries have a strong talent pool of more than 1,500 scientists, of which over 300 have PhDs and the balance hold master's degrees: drawn from the best domestic and international institutes and industry.
Some of our services are.
1. Innovative Process Research and Development, Catalysis, Crystallization and Flow Chemistry.
2. Scale-up of APIs under cGMP and nonGMP conditions in Princeton, NJ.
3. Synthesis of stable labeled metabolites and APIs, impurities, Glucuronides.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
